Analyzing host-viral interactome of SARS-CoV-2 for identifying vulnerable host proteins during COVID-19 pathogenesis

Jayanta Kumar Das1, Swarup Roy2, Pietro Hiram Guzzi3

  • 1Department of Pediatrics, School of Medicine, Johns Hopkins University, MD, USA.

Insights

Identifying key proteins in COVID-19 pathogenesis is crucial for developing new therapies. This study reveals central host proteins linked to respiratory diseases, offering potential therapeutic targets for COVID-19 treatment.

Area of Science:

  • Molecular Biology
  • Virology
  • Network Biology

Background:

  • Understanding COVID-19 pathogenesis requires identifying host molecular mechanisms.
  • Global research efforts have generated extensive data on protein and genetic interactions related to the virus.

Purpose of the Study:

  • To identify critical host proteins involved in COVID-19 pathogenesis.
  • To discover potential therapeutic targets for COVID-19 by analyzing host-pathogen interactions.

Main Methods:

  • Integrated global protein-protein interaction data to construct a human host network (1432 proteins).
  • Performed network centrality analysis to identify critical proteins.
  • Conducted functional enrichment analysis on central proteins.

Main Results:

  • The identified proteins are involved in cellular processes, signaling transduction, and neurodegenerative diseases.
  • Proteins associated with human respiratory tract diseases were prioritized.
  • Highlighted potential therapeutic targets including RBX1, HSPA5, ITCH, RAB7A, RAB5A, RAB8A, PSMC5, CAPZB, CANX, IGF2R, and HSPA1A.

Conclusions:

  • Network analysis identified key host proteins central to COVID-19 pathogenesis.
  • Several highlighted proteins are implicated in respiratory diseases, representing promising therapeutic targets.
  • This network-based approach aids in discovering novel therapeutic strategies for COVID-19.